MIVI TRUST

Related by string. * : MIVI . MIVI II . Inc. OTCBB MIVI . MIVI III / trusted . trusting . trusts . trust . Trusts . Trusted . Trusting . TRUSTED . TRUSTS . Truster . TRUSTING . Trust : Real Estate Investment Trusts . Digital Realty Trust . Primary Care Trust . UNIT TRUST AUSTRALIA . Land Trust . NHS Trust . NHS trusts . Properties Trust . Primary Care Trusts . Vornado Realty Trust . Trust OTCBB MOSH * *

Related by context. Frequent words. (Click for all words.) 62 Amrubicin 62 elotuzumab 61 phase IIb clinical 60 randomized Phase III 59 RTOG 59 NSABP 59 placebo controlled clinical 59 Phase Ib clinical 59 CCX# 59 phase IIa 58 prospective multicenter 58 GSK# [001] 58 Cloretazine R VNP#M 57 phase IIb 57 tesmilifene 57 PRECiSE 57 axitinib 57 Metastatic Melanoma 57 CR# vcMMAE 57 goserelin 57 double blinded placebo 57 placebo controlled Phase 57 HER2 positive metastatic breast 57 active comparator 57 prospective randomized controlled 57 Ischemic 56 Phase 2a trial 56 registrational trial 56 Multicenter 56 NLX P# 56 Phase 1b trial 56 imetelstat 56 tanespimycin 56 relapsed refractory multiple myeloma 56 Phenoptin 56 Azedra 56 metastatic renal cell carcinoma 56 Traficet EN 56 elagolix 56 Radiation Therapy Oncology 56 prospective observational 56 Torisel 56 Phase III Clinical Trial 55 Phase Ib 55 superficial bladder cancer 55 Pivotal Trial 55 Thrombolysis 55 Phase 1b 55 registrational 55 multicenter clinical 55 SWOG 55 ATTAIN 55 Pulmonary Arterial Hypertension 55 pertuzumab 55 mRCC 55 nab paclitaxel 55 Phase 2b clinical 55 multicentre 55 substudy 55 liver transplant recipients 55 TORISEL 55 Pivotal Phase 55 valopicitabine 54 Macroplastique 54 Epratuzumab 54 Neuradiab 54 subgroup analyzes 54 pharmacodynamic effects 54 ISTODAX 54 Myocardial Infarction 54 refractory multiple myeloma 54 adecatumumab 54 ocrelizumab 54 confirmatory Phase 3 54 Virulizin R 54 ataluren 54 StemEx 54 randomized controlled clinical 54 Fludara 54 azacitidine 54 cetrorelix 54 retinal vein occlusion 53 mCRC 53 RRMS patients 53 acute coronary syndromes ACS 53 Phase 2a clinical 53 Taxotere ® 53 malignant pleural mesothelioma 53 chemoradiotherapy 53 EORTC 53 allogeneic stem cell 53 placebo controlled clinical trials 53 neoadjuvant therapy 53 hepatitis C HCV 53 TASQ 53 Arch Neurol 53 immunohistochemical 53 retrospective cohort study 53 talabostat 53 Phase 2b trial 53 SYNTAX

Back to home page